Thrombotech's Unattributed Round

Thrombotech raised a round of funding on January 10, 2012.

Thrombotech is an Israeli biotechnological company that develops a peptide, THR-18, which allows the existing thrombolytic stroke medication to dissolve blood clots, diminishing life-threatening side …

Articles about Thrombotech's Unattributed Round: